Does Wall Street Rate Pfizer Inc. (PFE) Shares A Sell?


As of Wednesday close, Pfizer Inc.’s (NYSE:PFE) stock was down -$0.23, moving down -0.47 percent to $48.85. The average number of shares traded per day over the past five days has been 15,141,780 shares. 3 times new highs have been achieved over the past 5 days, with a $0.80 gain in that time frame. In the last twenty days, the average volume was 20,860,939, while in the previous 50 days, it was 20,641,926.

Since last month, PFE stock rose 7.15%. Shares of the company fell to $44.89 on 10/25/22, the lowest level in the past month. A 52-week high of $61.71 was reached on 01/03/22 after having rallying from a 52-week low of $41.44. Since the beginning of this year, PFE’s stock price has dropped by -17.27% or -$10.20, and marked a new high 1 time. However, the stock has declined by -20.84% since its 52-week high.

Do You Own These 7 Inflation-Survival Stocks?

Inflation is still near 40-year highs and rising prices are putting a big dent in our wallets. Unless you find out how to protect your portfolio and outpace inflation, you'll keep being at the mercy of economic factors out of your control. Especially since the price of electricity, food, and shelter are creeping up higher than ever. In this special report, I detail 7 stocks to help you survive and thrive in today's market. They're backed by solid companies, positioned to profit during tough economic times, and offer out-sized dividends to help you outpace inflation.

Click here to get your free copy of the report


PFE stock investors should be aware that Pfizer Inc. (PFE) stock had its last reported insider trading activity 171 days ago on Jun 07. DAMICO JENNIFER B., the SVP & Controller of the company, disposed of 4,218 shares for $53.96 on Jun 07. It resulted in a $227,603 divestment by the insider. DAMICO JENNIFER B. sold 4,000 shares at an average price of $50.50 on May 16. The insider now owns 15,064 shares following the transaction. On May 13, Executive Vice President SAHNI PAYAL sold 1,408 shares at $49.84 apiece. The transaction was valued at $70,175.

Valuation Metrics

Right now, Pfizer Inc. (PFE) has a P/E ratio of about 9.27. The stock’s beta is 0.68. Besides these, the trailing price-to-sales (P/S) ratio of 2.76, the price-to-book (PB) ratio of 2.96, and the price-to-cash flow ratio of 19.02 may also be considered.

The latest dividend of $0.40 per share was paid out, remained unchanged from last year’s $0.40. On Friday December 10 2021, a $0.01 dividend increase was announced.

Financial Health

In the three months ended September 29, Pfizer Inc.’s quick ratio stood at 1.40, while its current ratio was 1.60, showing that the company is able to pay off its debt. According to company report, the long-term debt-to-equity ratio for the quarter ending September 29 was 0.35, and the total debt-to-equity ratio was 0.40. On the profitability front, the trailing twelve-month gross margin is 65.50% percent. In the year ended September 29, operating margins totaled 36.10%. Based on annual data, PFE earned $50.47 billion in gross profit and brought in $81.29 billion in revenue.

A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was 18.90%. Return on equity (ROE) for the past 12 months was 35.10%.

In Pfizer Inc.’s quarter-end financial report for September 29, it reported total debt of $32.63 billion against cash and short-term investments of $34.83 billion. According to the earnings report, the company had a lower net income in the recent quarter than it did in the previous quarter. PFE’s revenue fell -6.43% to $27.74 billion during the quarter, while net income inched up to $22.64 billion. While analysts expected Pfizer Inc. to report $1.39 quarterly earnings, the actual figure was $1.78 per share, beating the consensus estimate by 28.10%. During the quarter, the company generated $10.13 billion in EBITDA. The liabilities of Pfizer Inc. were 102.46 billion at the end of its most recent quarter ended September 29, and its total debt was $37.0 billion. The value of shareholders’ equity is $5.61 billion.

Technical Picture

This quick technical analysis looks at Pfizer Inc.’s (PFE) price momentum. With a historical volatility rate of 22.10%, the RSI 9-day stood at 63.13% on 23 November.

With respect to its five-day moving average, the current Pfizer Inc. price is up by +1.66% percent or $0.80. At present, PFE shares trade +6.06% above its 20-day simple moving average and -5.40% percent below its 100-day simple moving average. However, the stock is currently trading approximately +5.85% above its SMA50 and -5.51% below its SMA200.

Stochastic coefficient K was 69.11% and Stochastic coefficient D was 63.32%, while ATR was 1.04. Given the Stochastic reading of 72.36% for the 14-day period, the RSI (14) reading has been calculated as 61.62%. As of today, the MACD Oscillator reading stands at 0.24, while the 14-day reading stands at 0.71.

Analyst Ratings

Credit Suisse launched its rating on Pfizer Inc. (NYSE: PFE) to an Outperform in a note to investors on November 18, 2022. Pfizer Inc. (PFE) has been rated Overweight by analysts. According to 0 brokerage firms, PFE is a sell, and 12 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 0 analysts rate Pfizer Inc. stock as buy, with 11 recommending it as overweight.

With a median target price of $52.65, the current consensus forecast for the stock is $44.00 – $75.00. Based on these forecasts, analysts predict Pfizer Inc. (PFE) will achieve an average price target of $54.35.


Please enter your comment!
Please enter your name here